Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03688230
What this trial is testing

Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
SFJ Pharmaceuticals X, LTD.
Testing effectiveness (Phase 2)UnknownNCT04466254
What this trial is testing

Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 75
Testing effectiveness (Phase 2)Study completedNCT02305758
What this trial is testing

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Untreated Metastatic Colorectal Cancer
AbbVie 130
Testing effectiveness (Phase 2)Ended earlyNCT01479465
What this trial is testing

Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Gilead Sciences 266
Testing effectiveness (Phase 2)Study completedNCT02743221
What this trial is testing

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 154
Testing effectiveness (Phase 2)Study completedNCT02246049
What this trial is testing

A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC

Who this might be right for
Colorectal Neoplasms
EPS Corporation 69
Testing effectiveness (Phase 2)UnknownNCT02296203
What this trial is testing

Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 27
Testing effectiveness (Phase 2)Looking for participantsNCT06341296
What this trial is testing

Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
West China Hospital 86
Large-scale testing (Phase 3)Study completedNCT03414983
What this trial is testing

An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread

Who this might be right for
Colorectal Cancer
Bristol-Myers Squibb 196
Testing effectiveness (Phase 2)Ended earlyNCT00961571
What this trial is testing

Sunitinib and Capecitabine for First Line Colon Cancer

Who this might be right for
Metastatic Colorectal Cancer
Georgetown University 50
Large-scale testing (Phase 3)Looking for participantsNCT06733038
What this trial is testing

FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 238
Early research (Phase 1)Study completedNCT00934882
What this trial is testing

Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI

Who this might be right for
Colorectal Neoplasms
Bayer 45
Large-scale testing (Phase 3)Active Not RecruitingNCT04854668
What this trial is testing

Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 748
Testing effectiveness (Phase 2)Ended earlyNCT01718808
What this trial is testing

Cetuximab for Elderly Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer
Swiss Cancer Institute 24
Testing effectiveness (Phase 2)UnknownNCT04262687
What this trial is testing

Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate

Who this might be right for
Colorectal Cancer MetastaticHigh Immune InfiltrateMicrosatellite Stable
Federation Francophone de Cancerologie Digestive 55
Testing effectiveness (Phase 2)Study completedNCT00423696
What this trial is testing

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
UNICANCER 145
Testing effectiveness (Phase 2)UnknownNCT02829385
What this trial is testing

Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients

Who this might be right for
Colorectal Neoplasms
Shoucheng Ma 53
Not applicableStudy completedNCT01533740
What this trial is testing

Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
University of Rome Tor Vergata 31
Testing effectiveness (Phase 2)Study completedNCT00109226
What this trial is testing

Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genentech, Inc.
Testing effectiveness (Phase 2)Study completedNCT01418222
What this trial is testing

FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genentech, Inc. 194
Next Page